Related Experiment Video
Updated: Nov 16, 2025
10:26
Monitoring Cell-to-cell Transmission of Prion-like Protein Aggregates in Drosophila Melanogaster
Published on: March 12, 2018
8.3K
Huntington's disease: lessons from prion disorders.
Melanie Alpaugh1,2, Francesca Cicchetti3,4
1Département de Psychiatrie & Neurosciences, Faculté de Médecine, Université Laval, Québec, QC, G1V 0A6, Canada. melanie.alpaugh@crchudequebec.ulaval.ca.
Journal of Neurology
|February 24, 2021
Summary
Huntington's disease may share mechanisms with prion disorders, suggesting potential for sporadic forms. This research offers new insights into neurodegenerative disease pathways and treatments.
Area of Science:
- Neuroscience
- Prion Biology
- Neurodegenerative Diseases
Background:
- Prion protein research has reshaped understanding of infectious agents.
- Findings are increasingly applied to neurodegenerative disorders like Alzheimer's and Parkinson's disease.
Purpose of the Study:
- To present evidence suggesting Huntington's disease shares features with prion disorders.
- To explore if similar pathogenic mechanisms govern Huntington's disease.
- To propose the potential existence of sporadic forms of Huntington's disease.
Main Methods:
- Comparative analysis of molecular and cellular mechanisms.
- Review of existing literature on prion diseases and Huntington's disease.
- Hypothesis generation based on shared pathological characteristics.
Main Results:
- Evidence suggests Huntington's disease exhibits characteristics similar to prion disorders.
- Shared mechanisms may underlie the progression of Huntington's disease.
- The concept of sporadic Huntington's disease is proposed.
Conclusions:
- Huntington's disease may be influenced by prion-like mechanisms.
- Further research into these shared pathways could reveal new therapeutic targets.
- The possibility of sporadic Huntington's disease warrants investigation.
Related Concept Videos
03:03Amyloid Fibrils
11.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.1K
01:15Parkinson's Disease: Overview
1.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K
01:37Neural Regulation
41.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.6K
01:22Lysosomal Hydrolases
4.2K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K